SR

Syed Reyaz Ahmad

Active Director Director DIN 06880550
DIN 06880550 First appointment Jun 2014 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2014
Shareholding value •••• Premium profile

About Syed Reyaz Ahmad

Data last updated:

Syed Reyaz Ahmad is a Director at Einzig Pharmaceutical Private Limited (since 2014). The company operates in Pharma. Einzig Pharmaceutical Private Limited reported revenue of ₹31.6 Lakh (FY 2017).

DIN 06880550
Primary Designation Director
Industry Pharma
First Appointment 27 Jun 2014
Oldest Company Age 12 yrs
Largest company Einzig Pharmaceutical Private Limited · ₹31.6 Lakh (FY 2017)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director27 Jun 20142014₹31.6 Lakh (FY 2017)Active

Board colleagues of Syed Reyaz Ahmad

NameDINCompanyDesignation
Naushad Ahmed00606050Einzig Pharmaceutical Private LimitedDirector

Directorship timeline

Open interactive timeline →
Einzig Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Syed Reyaz Ahmad

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Syed Reyaz Ahmad

Syed Reyaz Ahmad currently holds 1 directorship: Einzig Pharmaceutical Private Limited (Director, since 27 Jun 2014, revenue ₹31.6 Lakh (FY 2017)).

Syed Reyaz Ahmad was first appointed on 27 Jun 2014 as Director at Einzig Pharmaceutical Private Limited.

The current boards of Syed Reyaz Ahmad's companies include Naushad Ahmed (Einzig Pharmaceutical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available